Big Pharmas still looking for NASH drugs for which there is no approved treatment to date .. Pharmaxis is definitely one of the cheapest NASH player out there so i wouldnt be surprised if it gets bought the valuation of around US$56 million is a gift for this company .GL
Novo Nordisk obtains worldwide licence to potential NASH candidate...November 11, 2019
https://nordiclifescience.org/novo-nordisk-obtains-worldwide-licence-to-potential-nash-candidate/
- Forums
- ASX - By Stock
- SNT
- NASH Phase 2 results imminent --A $20+ BILLION Market
NASH Phase 2 results imminent --A $20+ BILLION Market, page-6
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $54.92M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $11.58K | 286.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 48760 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 19406 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48760 | 0.040 |
3 | 360214 | 0.039 |
3 | 1218558 | 0.038 |
2 | 550000 | 0.037 |
6 | 687200 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 128114 | 2 |
0.042 | 100000 | 1 |
0.043 | 200000 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 11.41am 15/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online